KATHRYN COLETTA: Open Payments
NPI 1821642372 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,282 in 63 payments from 17 companies in 2025. Trend: 2023 $1,157 · 2024 $1,537 · 2025 $1,282
Food & beverage: $1,282
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $203 |
| Janssen Biotech, Inc. | 8 | $172 |
| Sumitomo Pharma America, Inc. | 11 | $167 |
| Endo USA, Inc. | 4 | $106 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $96 |
| Novartis Pharmaceuticals Corporation | 5 | $94 |
| UROGEN PHARMA, INC. | 4 | $91 |
| Dendreon Pharmaceuticals LLC | 3 | $88 |
| IMMUNITYBIO, INC. | 3 | $69 |
| Procept Biorobotics Corporation | 1 | $61 |
Products named: ERLEADA, GEMTESA, XTANDI, Nubeqa, PLUVICTO, PROVENGE, AVEED, TALZENNA.
Industry payments across AL — which companies pay providers there.
